Vol. 4 No. 3 (2019): JAFF

Vol. 4 No. 3 (2019)

Published July 31, 2019
JAFF

Original Article

Andréia Dias Teixeira, Bárbara Cecília Oliveira Leite
Report of pharmaceutical activities in a municipality in Bahia in the supply of medicines not selected by SUS
https://doi.org/10.22563/2525-7323.2019.v4.n3.p.4-13
PDF - PORTUGUÊS (Português (Brasil))
Teresa Lemmer, Bernardo Pires, Ligia Yoshida, Marina Gaffo, Bruna Pegoretti, Luciana Vasconcelos
Minimum coverage lists on the private sector: international benchmarks review
https://doi.org/10.22563/2525-7323.2019.v4.n3.p.14-28
PDF - PORTUGUÊS (Português (Brasil))
Letícia Viatroski Carvalho, Alberi Adolfo Feltrin, Rafael José Vargas Alves, Karin Hepp Schwambach, Carine Raquel Blatt
Leuprorelide versus Goserelin to advanced prostate cancer: cost minimization analysis
https://doi.org/10.22563/2525-7323.2019.v4.n3.p.29-34
PDF - PORTUGUÊS (Português (Brasil))
Welly Araújo de Oliveira, Sérgio Ricardo Fernandes de Araújo
Pharmaceutical care strategies in primary health care
https://doi.org/10.22563/2525-7323.2019.v4.n3.p.35-47
PDF - PORTUGUÊS (Português (Brasil))
Reinaldo Flavio da Costa Ramalho, Flavio Mac Cord Medina
Advantages of the treat-and-extend regimen for the use of anti-VEGFs to treat AMD
https://doi.org/10.22563/2525-7323.2018.v2.n4.p.48-52
PDF - PORTUGUÊS (Português (Brasil))